Study of the interaction between S(-) bupivacaine and 2-hydroxypropyl-β-cyclodextrin

International Journal of Pharmaceutics

Volumn 331, Issue 1, 2007, Pages 99-106

  Moraes, Carolina Morales ^a   Abrami, Priscila ^a   de Paula, Eneida ^b   Braga, Angélica F A ^b   Fraceto, Leonardo Fernandes ^a,b  

^a UNIVERSITY OF SOROCABA   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

2 Hydroxypropyl cyclodextrin; HPLC; Nuclear magnetic resonance; S( ) Bupivacaine; Solubility isotherm

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; ACETONITRILE; BUFFER; BUPIVACAINE; LOCAL ANESTHETIC AGENT; PHOSPHATE; SODIUM CHANNEL;

ARTICLE; COMPLEX FORMATION; DRUG FORMULARY; DRUG SOLUBILITY; DRUG STABILITY; NERVE BLOCK; NERVE CONDUCTION; OBSTETRIC ANESTHESIA; PH; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVERSED PHASE LIQUID CHROMATOGRAPHY; SODIUM TRANSPORT; TEMPERATURE DEPENDENCE; THERMODYNAMICS;

ANESTHETICS, LOCAL; BETA-CYCLODEXTRINS; BUPIVACAINE; CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EXCIPIENTS; HYDROGEN-ION CONCENTRATION; MAGNETIC RESONANCE SPECTROSCOPY; SOLUBILITY; TEMPERATURE; THERMODYNAMICS;

EID: 33846684540     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2006.09.054     Document Type: Article

References (47)

1. Atwood J.L., Davies J.E.D., Macnicol D.D., and Vögtle F. Comprehensive supremolecular chemistry. In: Szejtli J., and Osa T. (Eds). Cyclodextrins vol. 3 (1996), Elsevier Science Ltd., Oxford
2. Bielejewska A., Duszczyk K., and Sybilska D. Influence of organic solvent on the behavior of camphor and alpha-pinene enantiomers in reversed-phase liquid chromatography systems with alpha-cyclodextrin as chiral additive. J. Chromatogr. A 931 (2001) 81-93
3. Connors K.A. The stability of cyclodextrin complexes in solution. Chem. Rev. 97 (1997) 1325-1357
4. Covino B.G., and Vassalo H.G. Local Anesthetics: Mechanisms of Action and Clinical Use (1976), Grune and Stratton, New York
5. de Araújo D.R., Moraes C.M., Fraceto L.F., Braga A.F.A., and de Paula E. Cyclodextrin-bupivacaine enantiomeric mixture (S75-R25) inclusion complex and intrathecal anesthesia in rats. Rev. Bras. Anestesiol. 56 (2006) 495-506
6. de Araújo D.R., Fraceto L.F., Braga A.F.A., and de Paula E. Drug-delivery systems for racemic bupivacaine (S50-R50) and bupivacaine enantiomeric mixture (S75-R25): cyclodextrins complexation effects on sciatic nerve blockade in mice. Rev. Bras. Anestesiol. 55 (2005) 316-328
7. de Araújo D.R., Pinto L.M.A., Braga A.F.A., and de Paula E. Local anesthetic formulation for controlled release: therapeutics applications. Rev. Bras. Anestesiol. 53 (2003) 663-671
8. de Jong R.H. Local Anesthetics (1994), C.C. Thomas, Springfield
9. Djedaïne F., Lin S.Z., Perly B., and Wouessidjewe D. High-field nuclear magnetic resonance techniques for the investigation of a β-cyclodextrin:indomethacin inclusion complex. J. Pharm. Sci. 79 (1990) 643-646
10. Dollo G., Le Corre P., Chevanne F., and Le Verge R. Inclusion complexation of amide-typed local anaesthetics with β-cyclodextrin and its derivatives. II: Evaluation of affinity constants and in vitro transfer rate constants. Int. J. Pharm. 136 (1996) 165-174
11. Dollo G., Le Corre P., Chevanne F., and Le Verge R. Inclusion complexation of amide-typed local anaesthetics with β-cyclodextrin and its derivatives. I: Physicochemical characterization. Int. J. Pharm. 131 (1996) 219-228
12. Dollo G., Le Corre P., Freville J.C., Chevanne F., and Le Verge R. Biopharmaceutics of local anesthetic-cyclodextrin complexes following loco-regional administration. Ann. Pharm. Fr. 58 (2000) 425-432
13. Dollo G., Thompson D.O., Le Corre P., Chevanne F., and Le Verge R. Inclusion complexation of amide-typed local anesthetics with β-cyclodextrin and its derivatives. III: Biopharmaceutics of bupivacaine-SBE7-βCD complex following percutaneous sciatic nerve administration in rabbits. Int. J. Pharm. 164 (1998) 11-19
14. Ellis III F.D., Seiler Jr. J.G., and Palmore M.M. Methemoglobinemia: a complication after fiberoptic orotracheal intubation with benzocaine spray. A case report. J. Bone Joint Surg. Am. 77 (1995) 937-939
15. Flood K.G., Reynolds E.R., and Snow N.H. Characterization of inclusion complexes of betamethasone-related steroids with cyclodextrins using high-performance liquid chromatography. J. Chromatogr. A 903 (2000) 49-65
16. Foster R.H., and Markham A. Levobupivacaine: a review of its pharmacology and use as a local anaesthetic. Drugs 59 (2000) 551-579
17. 1H-NMR measurements. Biophys. Chem. 115 (2005) 11-18
18. Freville J.C., Dollo G., Le Corre P., Chevanne F., and Le Verge R. Controlled systemic absorption and increased anesthetic effect of bupivacaine following epidural administration of bupivacaine-2-2-hydroxypropyl-beta-cyclodextrin complex. Pharm. Res. 13 (1996) 1576-1580
19. Gazpio C., Sánchez M., García-Zubiri I.X., Vélaz I., Martinez-Ohárriz C., Martín C., and Zornoza A. HPLC and solubility study of the interaction between pindolol and cyclodextrin. J. Pharm. Biomed. Anal. 9 (2004) 487-492
20. Gristwood R.W. Cardiac and CNS toxicity of levobupivacaine: strengths of evidence for advantage over bupivacaína. Drug Safety 25 (2002) 153-163
21. Higuchi T., and Connors K.A. Phase-solubility techniques. Adv. Anal. Chem. Inst. 4 (1965) 117-212
22. Hirayama F., and Uekama K. Cyclodextrin-based controlled drug release system. Adv. Drug Deliv. Rev. 36 (1999) 125-141
23. Huang Y.F., Pryor M.E., Mather L.E., and Veering B.T. Cardiovascular and central nervous system effects of intravenous levobupivacaine and bupivacaine in sheep. Anesth. Analg. 86 (1998) 797-804
24. Ismaili L., André C., Nicod L., Mozer J.L., Millet J., Refouvelet B., Makki S., Robert J.F., Xicluna A., and Guillaume Y.C. Chromatographic determination of the association constants between Psoralen derivatives and modified β-cyclodextrin: effect of sucrose as a co-enhancer association agent. J. Liq. Chromatogr. Relat. Technol. 26 (2003) 871-882
25. Karim A., Ahmed S., and Siddiqui R. Methemoglobinemia complicating topical lidocaine used during endoscopic procedures. J. Mattana Am. J. Med. 111 (2001) 150-153
26. Kern K., and Langevin P.B. Methemoglobinemia after topical anesthesia with lidocaine and benzocaine for a difficult intubation. J. Clin. Anesth. 12 (2000) 167-172
27. Liu Y., Jin L., and Zhang H.Y. Inclusion complexation thermodynamics of acridine red and rhodamine B by natural and novel oligo(ethylenediamine) tethered Schiff base β-cyclodextrin. J. Incl. Phenom. Macrocycl. Chem. 42 (2002) 115-120
28. Loftsson T., and Brewster M.E. Pharmaceutical applications of cyclodextrins. 1: Drug solubilization and stabilization. J. Pharm. Sci. 85 (1996) 1017-1025
29. Loukas Y.L., Vraka V., and Gregoriadis G. Novel non-acidic formulations of haloperidol complexed with beta-cyclodextrin derivatives. J. Pharm. Biomed. Anal. 16 (1997) 263-268
30. Martin Del Valle E.M. Cyclodextrin and their uses: a review. Process Biochem. 39 (2004) 1033-1046
31. Mather L.E., McCall P., and McNicol P.L. Bupivacaine enantiomer pharmacokinetics after intercostal neural blockade in liver transplantation patients. Anesth. Analg. 80 (1995) 328-335
32. Michaud M., and Icart S. Determination of the substitution of hydroxypropylbetadex using Fourier transform infrared spectrophotometry. Pharm. Eur. 13 (2001) 714-716
33. Morin N., Guillaume Y.C., Peyrin E., and Rouland J.C. Peculiarities of an imidazole derivative retention mechanism in reversed-phase liquid chromatography: β-cyclodextrin concentration and temperature considerations. J. Chromatogr. A 808 (1998) 51-60
34. Morin N., Guillaume Y.C., Peyrin E., and Rouland J.C. Retention behavior of d,l-dansyl-amino acids on a human serum albumin chiral stationary phase: effect of a mobile phase modifier. J. Chromatogr. A 808 (1998) 51-60
35. Rajewski R.A., and Stella V.J. Pharmaceutical applications of cyclodextrins. 2: In vivo drug delivery. J. Pharm. Sci. 85 (1996) 1142-1169
36. Ravelet C., Geze A., Villet A., Grosset C., Ravel A., Wouessid-jewe D., and Peyrin E. Chromatographic determination of the association constants between nimesulide and native and modified β-cyclodextrins. J. Pharm. Biomed. Anal. 29 (2002) 425-430
37. Ravelet C., Ravel A., Grosset C., Villet A., Geze A., Wouessidjewe D., and Peyrin E. Stoichiometry and formation constants of six PAHs with γ-cyclodextrin, determined by HPLC using a cyano stationary phase. J. Liq. Chromatogr. Relat. Technol. 25 (2002) 421-432
38. In: Ritchie J.M., and Strichartz G.R. (Eds). Local Anesthetics-Handbook of Experimental Pharmacology (1987), Springer-Verlag, Berlin
39. Rozou S., Voulgari A., and Antoniadou-Vyza E. The effect of pH dependent molecular conformation and dimerization phenomena of piroxicam on the drug:cyclodextrin complex stoichiometry and its chromatographic behavior: a new specific HPLC method for piroxicam:cyclodextrin formulations. Eur. J. Pharm. Sci. 21 (2004) 661-669
40. Sadlej-Sosnowska N. Relationships between binding of benzodiazepines to alpha-1-acid glycoprotein and human serum albumin and their retention on the protein and octadecylsilane columns. Eur. J. Pharm. Sci. 3 (1995) 1-5
41. Stalcup A.M., Chang S.S., Armstrong D.W., and Pitha J.J. (S)-2-2-2-Hydroxypropyl-beta-cyclodextrin, a new chiral stationary phase for reversed-phase liquid chromatography. J. Chromatogr. 513 (1990) 181-194
42. Tang J.J., and Love L.J.C. Formation constants of polynuclear aromatic compounds and β-cyclodextrin inclusion complexes in β-cyclodextrin modified mobile phase high performance liquid chromatography system. Anal. Chim. Acta 344 (1997) 137-143
43. Tommasini S., Raneri D., Ficarra R., Calabró M.L., Stancanelli R., and Ficarra P. Improvement in solubility and dissolution rate of flavonoids by complexation with beta-cyclodextrin. J. Pharm. Biomed. Anal. 35 (2004) 379-387
44. Tong W.Q., Lach J.L., Chin T.F., and Guillory J.K. Microcalorimetric investigation of the complexation between 2-2-2-hydroxypropyl-beta-cyclodextrin and amine drugs with the diphenylmethyl functionality. J. Pharm. Biomed. Anal. 9 (1991) 1139-1146
45. Uekama K., Hirayama F., and Irie T. The new method for determination of the stability constants of cyclodextrin-prostaglandin inclusion complexes by liquid chromatography. Chem. Lett. (1978) 661
46. Uekama K., Hirayama F., Nasu S., Matsuo N., and Irie T. Determination of the stability constants for inclusion complexes of cyclodextrins with various drug molecules by high performance liquid chromatography. Chem. Pharm. Bull. 26 (1978) 3477-3484
47. Xiliang G., Shaomin S., Chuan D., Feng F., and Wong M.S. Comparative study on the inclusion behavior between meso-tetrakis(4-N-ethylpyridiniurmyl)porphyrin and beta-cyclodextrin derivatives. Spectrochim. Acta Pt. A 61 (2005) 413-418